🛡️National Council on Disability
The National Council on Disability (NCD) will convene for a two-day meeting to address key issues impacting people with disabilities, including transportation, disaster preparedness, and healthcare training. The agenda includes panel discussions and a public comment period to gather insights from stakeholders and the community.
Learn More⚖️Antitrust Notice
The notice outlines the legal implications of UnitedHealth's proposed acquisition of Amedisys, emphasizing concerns over reduced competition in home health and hospice services, potential civil penalties, and the necessity for divestitures. Stakeholders are invited to submit comments within a 60-day window, reflecting the ongoing regulatory scrutiny of the merger.
Learn More💼Nurse Corps Loan Repayment Program Public Comment Request
In compliance with the Paperwork Reduction Act of 1995, HRSA submitted an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and approval. Comments submitted during the first public review of this ICR will be provided to OMB. OMB will accept further comments from the public during the review and approval period. OMB may act on HRSA's ICR only after the 30-day comment period for this notice has closed.
Learn More💵HRSA's Loan Repayment Programs for Substance Use Treatment Explained
In compliance with the requirement for opportunity for public comment on proposed data collection projects of the Paperwork Reduction Act of 1995, HRSA announces plans to submit an Information Collection Request (ICR), described below, to the Office of Management and Budget (OMB). Prior to submitting the ICR to OMB, HRSA seeks comments from the public regarding the burden estimate, below, or any other aspect of the ICR.
Learn More🏥CMS Notice on Information Collection Activities and Business Impact
The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency's functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden.
Learn More💵SSA and IRS Announce New Matching Program Affecting Medicare Premiums
In accordance with the provisions of the Privacy Act, as amended, this notice announces a new matching program with the United States Department of the Treasury, Internal Revenue Service (IRS). Under this matching program, the IRS will disclose to SSA certain tax return information for the purpose of establishing the correct amount of Medicare Part B premium subsidy adjustments and Medicare Part D premium increases provided under the Social Security Act (Act), the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Medicare Modernization Act), and the Affordable Care Act of 2010 (ACA).
Learn More💊Benuvia Operations LLC Applies for Controlled Substances Import Registration
Benuvia Operations, LLC. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💉FDA Draft Guidance on Iron Sucrose and Bioequivalence for Industry
The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a revised draft guidance for industry entitled "Draft Guidance on Iron Sucrose." This revised draft guidance, when finalized, will provide product-specific recommendations on, among other things, the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for iron sucrose intravenous injectable.
Learn More🩺DMICC Meeting on COVID-19 and New-Onset Diabetes Summary
The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on September 30th, 2025. The topic for this meeting will be "COVID-19 and New-Onset Diabetes."
Learn More🩺NIH National Advisory Council for Nursing Research Meeting Announcement
The Department of Health and Human Services announces a meeting of the National Advisory Council for Nursing Research, which will be open to the public and focus on grant applications. The meeting allows individuals to share comments and involves discussions that may impact funding and research directions in nursing. Further details are accessible on the NIH website.
Learn More